In addition, FcγR3B binding to both the WT and the beta VOC S and RBD were globally lower in vaccinees who ultimately developed COVID-19 compared with those who did not, pointing to a critical role for both S- and RBD-specific FcγR3B-binding antibodies in beta VOC immunity (Fig. 4a). This evidence concerns the gene FCGR3B and COVID-19.